GetTopicDetailResponse(id=57e21285269c, topicName=普依司他, introduction=, content=多發(fā)性骨髓瘤 普依司他, image=null, comments=0, allHits=149, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Jul 13 15:27:15 CST 2025, time=2025-07-13, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=506438, tagList=[TagDto(tagId=506438, tagName=普依司他)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2273174, encodeId=c4da22e317405, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多發(fā)性骨髓瘤#</a> <a href='/topic/show?id=57e21285269c' target=_blank style='color:#2F92EE;'>#普依司他#</a>, objectTitle=【STTT】新型選擇性HDAC I/IIb抑制劑甲磺酸普依司他治療復(fù)發(fā)難治性骨髓瘤和淋巴瘤的臨床前和I期研究結(jié)果, objectType=article, longId=886407, objectId=817788640eb7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220719/1658202183571_5552845.jpg, objectUrl=/article/show_article.do?id=817788640eb7, replyNumber=0, likeNumber=39, createdTime=2025-07-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=817788640eb7, moduleTitle=【STTT】新型選擇性HDAC I/IIb抑制劑甲磺酸普依司他治療復(fù)發(fā)難治性骨髓瘤和淋巴瘤的臨床前和I期研究結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=817788640eb7)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-07-13發(fā)表于上海
